| Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.PLoS One | Random groups | 2016 |
| Differential pulsatile secretagogue control of GH secretion in healthy men.Am J Physiol Regul Integr Comp Physiol | Random groups | 2013 |
| Regulated recovery of pulsatile growth hormone secretion from negative feedback: a preclinical investigation.Am J Physiol Regul Integr Comp Physiol | Random groups | 2011 |
| Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.J Clin Endocrinol Metab | Random groups | 2011 |
| Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp.Am J Physiol Endocrinol Metab | Random groups | 2011 |
| Secretagogue type, sex-steroid milieu, and abdominal visceral adiposity individually determine secretagogue-stimulated cortisol secretion.Eur J Endocrinol | Random groups | 2010 |
| Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.J Clin Endocrinol Metab | Random groups | 2010 |
| Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.Am J Physiol Endocrinol Metab | Random groups | 2009 |
| Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.Eur J Endocrinol | Random groups | 2009 |
| Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.J Clin Endocrinol Metab | Random groups | 2009 |
| Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.J Clin Endocrinol Metab | Random groups | 2009 |
| Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.Am J Physiol Endocrinol Metab | Random groups | 2009 |
| Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.J Clin Endocrinol Metab | Random groups | 2009 |
| Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.J Clin Endocrinol Metab | Random groups | 2008 |
| Peripheral estrogen receptor-alpha selectively modulates the waveform of GH secretory bursts in healthy women.Am J Physiol Regul Integr Comp Physiol | Random groups | 2007 |
| Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model.Am J Physiol Regul Integr Comp Physiol | Random groups | 2007 |
| Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake.Obesity (Silver Spring) | Random groups | 2006 |
| Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.Eur J Endocrinol | Random groups | 2005 |
| Short-term testosterone supplementation does not activate GH and IGF-I production in postmenopausal women.Clin Endocrinol (Oxf) | Random groups | 2005 |
| Joint mechanisms of impaired growth-hormone pulse renewal in aging men.J Clin Endocrinol Metab | Random groups | 2005 |
| Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.J Clin Endocrinol Metab | Random groups | 2005 |
| Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults.J Clin Endocrinol Metab | Random groups | 2004 |
| Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.J Clin Endocrinol Metab | Random groups | 2004 |
| Short-term testosterone supplementation relieves growth hormone autonegative feedback in men.J Clin Endocrinol Metab | Random groups | 2004 |
| Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.J Clin Endocrinol Metab | Random groups | 2002 |
| E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.J Clin Endocrinol Metab | Random groups | 2001 |
| Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.J Clin Endocrinol Metab | Random groups | 2000 |
| Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.J Clin Endocrinol Metab | Random groups | 2000 |
| Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.J Clin Endocrinol Metab | Random groups | 1999 |
| Preservation of growth hormone secretion in response to growth hormone-releasing peptide-2 during prednisone therapy.Metabolism | Random groups | 1999 |
| Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.J Clin Endocrinol Metab | Random groups | 1999 |
| Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.J Endocrinol Invest | Random groups | 1999 |
| Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.Eur J Endocrinol | Random groups | 1999 |
| Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.J Clin Endocrinol Metab | Random groups | 1998 |
| Evidence against a role for the growth hormone-releasing peptide axis in human slow-wave sleep regulation.Am J Physiol | Random groups | 1998 |
| Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.J Clin Endocrinol Metab | Random groups | 1998 |
| Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.Clin Endocrinol (Oxf) | Random groups | 1997 |
| The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.J Clin Endocrinol Metab | Random groups | 1997 |
| Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.Clin Endocrinol (Oxf) | Random groups | 1996 |
| Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short stature.Metabolism | Random groups | 1995 |
| GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers.Clin Endocrinol (Oxf) | Random groups | 1995 |
| Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.Endocr J | No random groups | 2016 |
| Secretagogues govern GH secretory-burst waveform and mass in healthy eugonadal and short-term hypogonadal men.Eur J Endocrinol | No random groups | 2008 |
| Tripartite control of growth hormone secretion in women during controlled estradiol repletion.J Clin Endocrinol Metab | No random groups | 2007 |
| GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome.J Endocrinol Invest | No random groups | 2006 |
| Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children.J Pediatr Endocrinol Metab | No random groups | 2003 |
| Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.Endocrine | No random groups | 2001 |
| Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise.Am J Physiol Regul Integr Comp Physiol | No random groups | 2000 |
| A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.J Clin Endocrinol Metab | No random groups | 2000 |
| Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children.J Clin Endocrinol Metab | No random groups | 1998 |
| Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.J Clin Endocrinol Metab | No random groups | 1998 |
| Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.J Endocrinol | No random groups | 1997 |
| GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans.J Pediatr Endocrinol Metab | No random groups | 1996 |
| Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.J Clin Endocrinol Metab | No random groups | 1995 |
| One Case of Sudden Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Diagnosed Based on Repeated Hypoglycemic Attacks.Cureus | Case reports | 2025 |
| Idiopathic combined adrenocorticotropin and growth hormone deficiency mimicking chronic fatigue syndrome.BMJ Case Rep | Case reports | 2021 |
| ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review.AACE Clin Case Rep | Case reports | 2021 |
| Idiopathic and isolated adrenocorticotropic hormone deficiency presenting as continuous epigastric discomfort without symptoms of hypoglycemia: a case report.J Med Case Rep | Case reports | 2019 |
| Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell Carcinoma.Tokai J Exp Clin Med | Case reports | 2017 |
| Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-.Endocr J | Case reports | 2010 |
| Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.Endocr J | Case reports | 2010 |
| Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.Neurol Med Chir (Tokyo) | Case reports | 2009 |
| Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.Sex Med Rev | Review of studies | 2026 |
| The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Front Endocrinol (Lausanne) | Review of studies | 2026 |
| Pharmacotherapy in Cachexia: A Review of Endocrine Abnormalities and Steroid Pharmacotherapy.J Pain Palliat Care Pharmacother | Review of studies | 2022 |
| Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.Transl Androl Urol | Review of studies | 2020 |
| The Safety and Efficacy of Growth Hormone Secretagogues.Sex Med Rev | Review of studies | 2018 |
| Ghrelin Receptor Ligands Reaching Clinical Trials: From Peptides to Peptidomimetics; from Agonists to Antagonists.Horm Metab Res | Review of studies | 2016 |
| Adult growth hormone deficiency: current concepts.Neurol Med Chir (Tokyo) | Review of studies | 2014 |
| [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].Brain Nerve | Review of studies | 2008 |
| Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.Drugs R D | Review of studies | 2004 |
| Sex-steroid modulation of growth hormone (GH) secretory control: three-peptide ensemble regulation under dual feedback restraint by GH and IGF-I.Endocrine | Review of studies | 2003 |
| Gateways to clinical trials.Methods Find Exp Clin Pharmacol | Review of studies | 2002 |
| Body composition, physical exercise, growth hormone and obesity.Eat Weight Disord | Review of studies | 2001 |
| Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.Endocrine | Review of studies | 2001 |
| Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?Clin Exp Pharmacol Physiol | Review of studies | 2000 |
| Growth hormone-releasing peptides and the cardiovascular system.Ann Endocrinol (Paris) | Review of studies | 2000 |
| Orally active growth hormone secretagogues: state of the art and clinical perspectives.Ann Med | Review of studies | 1998 |
| New GH secretagogues and potential usefulness in thalassemia.J Pediatr Endocrinol Metab | Review of studies | 1998 |
| Growth hormone-releasing peptides and their analogs.Front Neuroendocrinol | Review of studies | 1998 |
| Growth hormone-releasing peptides.Eur J Endocrinol | Review of studies | 1997 |
| Growth hormone-releasing peptides: clinical and basic aspects.Horm Res | Review of studies | 1996 |
| Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys.In Vivo | In animals | 2026 |
| Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.Arthroscopy | In animals | 2025 |
| β1-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress.Neuropsychopharmacology | In animals | 2019 |
| Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.AAPS PharmSciTech | In animals | 2015 |
| Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.Peptides | In animals | 2014 |
| Intraportal infusion of ghrelin could inhibit glucose-stimulated GLP-1 secretion by enteric neural net in Wistar rat.Biomed Res Int | In animals | 2014 |
| Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice.Peptides | In animals | 2013 |
| Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.Anal Bioanal Chem | In animals | 2013 |
| Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.Mol Cell Endocrinol | In animals | 2012 |
| Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice.Clinics (Sao Paulo) | In animals | 2012 |
| Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.Tohoku J Exp Med | In animals | 2010 |
| Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.Circ J | In animals | 2010 |
| Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary.Regul Pept | In animals | 2009 |
| Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats.Peptides | In animals | 2009 |
| GHRP-2 attenuates burn-induced dysfunctions in rodents.Adv Exp Med Biol | In animals | 2009 |
| The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.J Gastroenterol | In animals | 2009 |
| Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.World J Gastroenterol | In animals | 2008 |
| GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1.Life Sci | In animals | 2008 |
| GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.Am J Physiol Endocrinol Metab | In animals | 2008 |
| Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.Regul Pept | In animals | 2007 |
| Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH.Endocrine | In animals | 2006 |
| KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts.Naunyn Schmiedebergs Arch Pharmacol | In animals | 2006 |
| Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2.Endocrinology | In animals | 2005 |
| Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.Am J Physiol Endocrinol Metab | In animals | 2005 |
| Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.Am J Physiol Endocrinol Metab | In animals | 2005 |
| Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats.Drug Metab Dispos | In animals | 2005 |
| Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.Am J Physiol Endocrinol Metab | In animals | 2005 |
| Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma IGF-1 and IGFBPs in Holstein steers.Domest Anim Endocrinol | In animals | 2005 |
| Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse.Neuroendocrinology | In animals | 2005 |
| ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.Naunyn Schmiedebergs Arch Pharmacol | In animals | 2005 |
| Regulation of ghrelin gene expression in stomach and feeding response to a ghrelin analogue in two strains of rats.Peptides | In animals | 2004 |
| Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.Eur J Endocrinol | In animals | 2004 |
| General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.Arzneimittelforschung | In animals | 2004 |
| Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.Arzneimittelforschung | In animals | 2004 |
| Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness.Endocrinology | In animals | 2004 |
| Development of an enzyme-linked immunosorbent assay for the measurement of plasma growth hormone (GH) levels in channel catfish (Ictalurus punctatus): assessment of environmental salinity and GH secretogogues on plasma GH levels.Gen Comp Endocrinol | In animals | 2003 |
| Growth hormone-releasing peptide-2 reduces inward rectifying K+ currents via a PKA-cAMP-mediated signalling pathway in ovine somatotropes.J Physiol | In animals | 2002 |
| Chicken ghrelin and growth hormone-releasing peptide-2 inhibit food intake of neonatal chicks.Eur J Pharmacol | In animals | 2002 |
| The effect of two-day treatment of primary cultured ovine somatotropes with GHRP-2 on membrane voltage-gated K+ currents.Endocrinology | In animals | 2002 |
| Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?Endocrinology | In animals | 2002 |
| A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response.Endocrinology | In animals | 2002 |
| GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.Endocrinology | In animals | 2002 |
| Direct modification of somatotrope function by long-term leptin treatment of primary cultured ovine pituitary cells.Endocrinology | In animals | 2001 |
| The in vitro effect of leptin on growth hormone secretion from primary cultured ovine somatotrophs.Endocrine | In animals | 2001 |
| Plasma growth hormone (GH) responses after administration of the peptidergic GH secretagogue KP102 into the oral cavity, rumen, abomasum and duodenum in adult goats.Domest Anim Endocrinol | In animals | 2001 |
| Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine.Domest Anim Endocrinol | In animals | 2001 |
| The effect of growth hormone-releasing peptide-2 (KP102) administration on plasma insulin-like growth factor (IGF)-1 and IGF-binding proteins in Holstein steers on different planes of nutrition.Domest Anim Endocrinol | In animals | 2000 |
| The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine.Domest Anim Endocrinol | In animals | 2000 |
| Oral administration of peptidergic growth hormone (GH) secretagogue KP102 stimulates GH release in goats.Domest Anim Endocrinol | In animals | 1999 |
| Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.Xenobiotica | In animals | 1998 |
| Ipamorelin, the first selective growth hormone secretagogue.Eur J Endocrinol | In animals | 1998 |
| A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.J Med Chem | In animals | 1998 |
| Intrahypothalamic perfusion of KP102 stimulates growth hormone release in goats.Endocr J | In animals | 1998 |
| Effects of muscarinic and adrenergic blockade on growth hormone secretion induced by growth hormone-releasing peptide-2 (GHRP-2) in ovariectomized ewes.Endocr J | In animals | 1997 |
| No desensitization of the growth hormone (GH) response between GH-releasing peptide-2 and GH-releasing factor in calves.J Anim Sci | In animals | 1997 |
| Mechanisms of action of growth hormone-releasing peptide-2 in bovine pituitary cells.J Anim Sci | In animals | 1997 |
| The role of protein kinase C in GH secretion induced by GH-releasing factor and GH-releasing peptides in cultured ovine somatotrophs.J Endocrinol | In animals | 1997 |
| Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells.Life Sci | In animals | 1997 |
| Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.Endocr J | In animals | 1996 |
| Differentiating hypothalamic from pituitary adrenal insufficiency: underlying causes and diagnostic utility of the corticotropin-releasing hormone and growth hormone-releasing peptide-2 stimulation tests.Endocr J | Other paper | 2026 |
| Possible Involvement of Hypothalamic Dysfunction in Long COVID Patients Characterized by Delayed Response to Gonadotropin-Releasing Hormone.Int J Mol Sci | Other paper | 2026 |
| Benchmark for Setting ACTH Cell Dosage in Clinical Regenerative Medicine for Post-Operative Hypopituitarism.Diseases | Other paper | 2025 |
| Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19.Biology (Basel) | Other paper | 2023 |
| Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly.Growth Horm IGF Res | Other paper | 2023 |
| Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.J Endocr Soc | Other paper | 2022 |
| Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.PLoS One | Other paper | 2022 |
| Refractory hypoglycaemia in a localised gastrointestinal stromal tumour: Case report.Int J Surg Case Rep | Other paper | 2021 |
| On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.Drug Test Anal | Other paper | 2021 |
| Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.Mol Divers | Other paper | 2021 |
| Determination of the immunostimulatory drug-glucosoaminyl-muramyl-dipeptide-in human plasma using HPLC-MS/MS and its application to a pharmacokinetic study.Biomed Chromatogr | Other paper | 2020 |
| Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS.Anal Bioanal Chem | Other paper | 2020 |
| Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.Endocr J | Other paper | 2020 |
| Detection of black market follistatin 344.Drug Test Anal | Other paper | 2019 |
| Glycine-modified growth hormone secretagogues identified in seized doping material.Drug Test Anal | Other paper | 2019 |
| Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial.Drug Test Anal | Other paper | 2019 |
| Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.Endocr J | Other paper | 2018 |
| Evaluation of Hypothalamic-Pituitary-Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test.J Endocr Soc | Other paper | 2018 |
| Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.Am J Mens Health | Other paper | 2017 |
| Laparoscopic Sleeve Gastrectomy Resolves Low GHRP-2-Stimulated Growth Hormone Levels in Obese Patients.Obes Surg | Other paper | 2017 |
| Structure-activity relationship for peptídic growth hormone secretagogues.Drug Test Anal | Other paper | 2017 |
| Genetic and protein biomarkers in blood for the improved detection of GH abuse.J Pharm Biomed Anal | Other paper | 2016 |
| Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells.Int J Mol Sci | Other paper | 2016 |
| Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.J Sep Sci | Other paper | 2016 |
| Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.Drug Test Anal | Other paper | 2015 |
| One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient.J Cachexia Sarcopenia Muscle | Other paper | 2015 |
| Detection of GHRP-2 and GHRP-6 in urine samples from athletes.Drug Test Anal | Other paper | 2015 |
| In vitro models for metabolic studies of small peptide hormones in sport drug testing.J Pept Sci | Other paper | 2015 |
| Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency.Clin Pediatr Endocrinol | Other paper | 2014 |
| A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography.Drug Test Anal | Other paper | 2014 |
| Adult growth hormone deficiency: current concepts.Neurol Med Chir (Tokyo) | Other paper | 2014 |
| Urinary growth hormone level and insulin-like growth factor-1 standard deviation score (IGF-SDS) can discriminate adult patients with severe growth hormone deficiency.Endocr J | Other paper | 2013 |
| The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison.Endocr J | Other paper | 2013 |
| Metabolism of growth hormone releasing peptides.Anal Chem | Other paper | 2012 |
| Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry.J Chromatogr A | Other paper | 2012 |
| Growth hormone secretagogues: out of competition.Anal Bioanal Chem | Other paper | 2012 |
| Doping control analysis of selected peptide hormones using LC-MS(/MS).Forensic Sci Int | Other paper | 2011 |
| High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.Drug Test Anal | Other paper | 2011 |
| Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells.Mol Cell Endocrinol | Other paper | 2011 |
| Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.Anal Bioanal Chem | Other paper | 2011 |
| Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects.Drug Test Anal | Other paper | 2010 |
| Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.Rapid Commun Mass Spectrom | Other paper | 2010 |
| Growth hormone response to GH-releasing peptide-2 in children.J Pediatr Endocrinol Metab | Other paper | 2010 |
| Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.Peptides | Other paper | 2010 |
| Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement.Drug Test Anal | Other paper | 2010 |
| GH-releasing peptide-2 does not stimulate arginine vasopressin secretion in healthy men.Endocr J | Other paper | 2010 |
| Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.Endocrinology | Other paper | 2009 |
| Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.Endocr J | Other paper | 2008 |
| Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency.Nat Clin Pract Endocrinol Metab | Other paper | 2008 |
| Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.J Clin Endocrinol Metab | Other paper | 2005 |
| Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.J Clin Endocrinol Metab | Other paper | 2005 |
| Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription.Comp Biochem Physiol C Toxicol Pharmacol | Other paper | 2004 |
| Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.J Clin Endocrinol Metab | Other paper | 2004 |
| Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.J Clin Endocrinol Metab | Other paper | 2004 |
| Gateways to clinical trials.Methods Find Exp Clin Pharmacol | Other paper | 2003 |
| Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor.J Clin Endocrinol Metab | Other paper | 2001 |
| Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.Endocrine | Other paper | 2001 |
| Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.J Clin Endocrinol Metab | Other paper | 2001 |